Mirati Therapeutics Company Profile (OTCMKTS:MYLGF)

About Mirati Therapeutics (OTCMKTS:MYLGF)

Mirati Therapeutics logoMethylGene, Inc. operates as a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics for cancer and infectious disease.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:MYLGF
  • CUSIP: N/A
  • Web: N/A
P/E:
  • Trailing P/E Ratio:
  • P/E Growth:
Dividend:
  • Dividend Yield: 1.0%
 

Frequently Asked Questions for Mirati Therapeutics (OTCMKTS:MYLGF)

What is Mirati Therapeutics' stock symbol?

Mirati Therapeutics trades on the OTCMKTS under the ticker symbol "MYLGF."

Who are some of Mirati Therapeutics' key competitors?

How do I buy Mirati Therapeutics stock?

Shares of Mirati Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mirati Therapeutics' stock price today?

One share of Mirati Therapeutics stock can currently be purchased for approximately $0.12.


MarketBeat Community Rating for Mirati Therapeutics (OTCMKTS MYLGF)
Community Ranking:  3.4 out of 5 (  )
Outperform Votes:  22 (Vote Outperform)
Underperform Votes:  10 (Vote Underperform)
Total Votes:  32
MarketBeat's community ratings are surveys of what our community members think about Mirati Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Mirati Therapeutics (OTCMKTS:MYLGF) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Mirati Therapeutics (OTCMKTS:MYLGF)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Mirati Therapeutics (OTCMKTS:MYLGF)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Mirati Therapeutics (OTCMKTS:MYLGF)
Current Year EPS Consensus Estimate: $0.00 EPS
Next Year EPS Consensus Estimate: $0.00 EPS

Dividends

Dividend History for Mirati Therapeutics (OTCMKTS:MYLGF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mirati Therapeutics (OTCMKTS:MYLGF)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Mirati Therapeutics (OTCMKTS:MYLGF)
Latest Headlines for Mirati Therapeutics (OTCMKTS:MYLGF)
Source:
No headlines for this company have been tracked by MarketBeat.com

Social

Chart

Mirati Therapeutics (MYLGF) Chart for Saturday, August, 19, 2017

This page was last updated on 8/19/2017 by MarketBeat.com Staff